In NHL and ALL, overexpression of the antiapoptotic proteins Bcl-2 [20, 21, 52], Bcl-XL [22, 23, 52], and Mcl-1 [52, 53] have been documented to be associated with drug resistance. This evidence concerns the gene BCL2L1 and acute lymphoblastic leukemia.